Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Revenue

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹141 Cr₹115 Cr₹11,271,608 Cr₹126 Cr₹123 Cr

What is the latest Revenue of MEDICAMEN BIOTECH ?

The latest Revenue ratio of MEDICAMEN BIOTECH is ₹141 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹141 Cr
Mar2023₹115 Cr
Mar2022₹11,271,608 Cr
Mar2021₹126 Cr
Mar2020₹123 Cr

How is Revenue of MEDICAMEN BIOTECH Trending?

Years Revenue % Change
Mar2024 ₹141 Cr
22.02
Mar2023 ₹115 Cr
-100.00
Mar2022 ₹11,271,608 Cr
8,980,974.92
Mar2021 ₹126 Cr
2.37
Mar2020 ₹123 Cr -

Compare Revenue of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹475.7 Cr -1.7% -13.5% -8.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,192.0 Cr 0.3% -4% -6.3% Stock Analytics
DIVIS LABORATORIES ₹161,479.0 Cr 2% -9.6% 33.1% Stock Analytics
CIPLA ₹125,113.0 Cr 1.9% 4.5% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,539.0 Cr 0.6% 3.6% 9.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,926.0 Cr 2% -1% -7% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-1.7%

-13.5%

-8.8%

SENSEX

1.3%

-0.8%

3.2%


You may also like the below Video Courses